This piece in 1993 also provided new insights into the biology of exendin, namely that exendin-4 was a full agonist of the human GLP-1 receptor, which Mojsov argues was crucial to convincing Amylin to develop exendin as a drug for diabetes (see below)
Previewing major regulatory, market access and political themes
"We see much greater success when lifestyle changes are part of the plan." Lifestyle adjustments can make a big difference
Who Is This For
Arenas J, Huertas R, Campos Y, Diaz AE, Villalon JM, Vilas E
Furthermore, exenatide enhanced the expression of phosphorylated ERK and M2-type microglial markers, demonstrating its neuroprotective and anti-inflammatory effects